Further structure-activity relationships study of hybrid 7-{[2-(4-phenylpiperazin-1-yl)ethyl]propylamino}-5,6,7,8-tetrahydronaphthalen-2-ol analogues: identification of a high-affinity D3-preferring agonist with potent in vivo activity with long duration of action.

作者: Swati Biswas , Suhong Zhang , Fernando Fernandez , Balaram Ghosh , Juan Zhen

DOI: 10.1021/JM070860R

关键词: MethyleneStructural isomerChemistrySelectivityCatecholAgonistStereochemistryLinkerChemical synthesisReceptor

摘要: This paper describes an extended structure–activity relationships study of aminotetralin−piperazine-based hybrid molecules developed earlier for dopamine D2/D3 receptors. Various analogues as positional isomers have been where location the phenolic hydroxyl group has varied on aromatic ring. Between two catechol derivatives, compound 6e with a methylene linker length exhibited higher affinity and selectivity D3 over D2 receptors 6f four linkers (D2/D3 = 50.6 vs 7.51 6f, respectively). In general, (−)-isomer was more potent than (+)-isomeric counterpart. Binding results indicated highest in (−)-10 (Ki 0.35 nM; 71). 5-hydroxy series, by (−)-25 0.82 31.5). Most compounds binding functional affinities at sub-nanomolar level receptor. assays were carried out w...

参考文章(52)
CRISTINA MISSALE, S. RUSSEL NASH, SUSAN W. ROBINSON, MOHAMED JABER, MARC G. CARON, Dopamine Receptors: From Structure to Function Physiological Reviews. ,vol. 78, pp. 189- 225 ,(1998) , 10.1152/PHYSREV.1998.78.1.189
Pierre Sokoloff, Bruno Giros, Marie-Pascale Martres, Marie-Louise Bouthenet, Jean-Charles Schwartz, Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature. ,vol. 347, pp. 146- 151 ,(1990) , 10.1038/347146A0
CE Clarke, M Guttman, Dopamine agonist monotherapy in Parkinson's disease The Lancet. ,vol. 360, pp. 1767- 1769 ,(2002) , 10.1016/S0140-6736(02)11668-0
J JOYCE, M MILLAN, Dopamine D3 receptor agonists for protection and repair in Parkinson's disease. Current Opinion in Pharmacology. ,vol. 7, pp. 100- 105 ,(2007) , 10.1016/J.COPH.2006.11.004
Aloke K Dutta, Sylesh K Venkataraman, Xiang-Shu Fei, Rohit Kolhatkar, Shijun Zhang, Maarten E.A Reith, Synthesis and biological characterization of novel hybrid 7-[[2-(4-phenyl-piperazin-1-yl)-ethyl]-propyl-amino]-5,6,7,8-tetrahydro-naphthalen-2-ol and their heterocyclic bioisosteric analogues for dopamine D2 and D3 receptors. Bioorganic & Medicinal Chemistry. ,vol. 12, pp. 4361- 4373 ,(2004) , 10.1016/J.BMC.2004.06.019
Joseph G. Cannon, Teresa Lee, H. Duane Goldman, Brenda Costall, Robert J. Naylor, Cerebral dopamine agonist properties of some 2-aminotetralin derivatives after peripheral and intracerebral administration Journal of Medicinal Chemistry. ,vol. 20, pp. 1111- 1116 ,(1977) , 10.1021/JM00219A001
Erwan Bézard, Sandrine Ferry, Ulrich Mach, Holger Stark, Ludovic Leriche, Thomas Boraud, Christian Gross, Pierre Sokoloff, Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function. Nature Medicine. ,vol. 9, pp. 762- 767 ,(2003) , 10.1038/NM875
Jeffrey N. Joyce, Dopamine D3 receptor as a therapeutic target for antipsychotic and antiparkinsonian drugs Pharmacology & Therapeutics. ,vol. 90, pp. 231- 259 ,(2001) , 10.1016/S0163-7258(01)00139-5
Kim Y Avenell, Izzy Boyfield, Michael S Hadley, Christopher N Johnson, David J Nash, Graham J Riley, Geoffrey Stemp, Heterocyclic analogues of 2-aminotetralins with high affinity and selectivity for the dopamine D3 receptor. Bioorganic & Medicinal Chemistry Letters. ,vol. 9, pp. 2715- 2720 ,(1999) , 10.1016/S0960-894X(99)00454-0
A. Crider, Mark Scheideler, Recent advances in the development of dopamine D(3) receptor agonists and antagonists. Mini-reviews in Medicinal Chemistry. ,vol. 1, pp. 89- 99 ,(2001) , 10.2174/1389557013407287